December 22, 2022
Study by Tufts CSDD uncovers potential reasons behind CRA shortages, turnover, experience requirements, and more.
July 27, 2022
Tufts CSDD study in collaboration with ten biopharmaceutical organizations and CROs examines sponsor/CRO relationships.
November 15, 2021
Improving receptivity and response to the evolving nature of clinical trial patient oversight.
July 13, 2021
A summary of how organizations approached remote operating models and the experiences and effectiveness of clinical research professionals in their roles and responsibilities during the COVID-19 pandemic.
October 22, 2020
Findings from a Tufts study examining the effects of COVID-19 on clinical trials.
May 26, 2020
Tufts Center for the Study of Drug Development and Biogen recently conducted a study to inform growing interest in improving diversity of clinical trial participation. The results of this research provide insights into increasing the community of minority investigators and study staff and presenting greater access to clinical trials among minority study volunteers.